Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP

Abstract Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP...

Full description

Bibliographic Details
Main Authors: Valeria Dipasquale, Marco Deganello Saccomani, Angelo Di Giorgio, Salvatore Oliva, Silvia Salvatore, Caterina Strisciuglio, Renato Tambucci, Paolo Lionetti, Claudio Romano
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Italian Journal of Pediatrics
Subjects:
Anti-TNF-α
COVID-19
Digestive endoscopy
Hepatitis
Inflammatory bowel disease
Liver disease
Online Access:https://doi.org/10.1186/s13052-023-01418-7
Description
Summary:Abstract Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.
ISSN:1824-7288

Similar Items